Letter to the Editor: Time for validating GEMA-Na in the United States for liver transplant waiting list prioritization.

IF 4.7 2区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY

Liver Transplantation Pub Date : 2024-09-10 DOI:10.1097/LVT.0000000000000483

Manuel L Rodríguez-Perálvarez, Avik Majumdar, Emmanuel Tsochatzis

引用次数: 0

查看原文本刊更多论文

致编辑：在美国验证 GEMA-Na 用于肝移植候选名单优先排序的时机已到。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Liver Transplantation 医学-外科

CiteScore

7.40

自引率

6.50%

发文量

254

审稿时长

3-8 weeks

期刊介绍： Since the first application of liver transplantation in a clinical situation was reported more than twenty years ago, there has been a great deal of growth in this field and more is anticipated. As an official publication of the AASLD, Liver Transplantation delivers current, peer-reviewed articles on liver transplantation, liver surgery, and chronic liver disease — the information necessary to keep abreast of this evolving specialty.